Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruoding Tan

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Gastro Hep Advances|June 20, 2025
Early-Onset Colorectal Cancer Survival by Race and Ethnicity in a Large Community-Based Insured PopulationJames H-E Kang, Christopher D Jensen, Natalia Udaltsova, et al.
Journal of Hepatocellular Carcinoma|April 24, 2025
Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Real-World Experience From a US Community Oncology NetworkDavid Cosgrove, Ruoding Tan, Andrew J Osterland, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Gastro Hep Advances|June 20, 2025
Early-Onset Colorectal Cancer Survival by Race and Ethnicity in a Large Community-Based Insured PopulationJames H-E Kang, Christopher D Jensen, Natalia Udaltsova, et al.
Journal of Hepatocellular Carcinoma|April 24, 2025
Atezolizumab Plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Real-World Experience From a US Community Oncology NetworkDavid Cosgrove, Ruoding Tan, Andrew J Osterland, et al.
Pageof 2